Edwards Lifesciences downgraded by Wolfe Research with a new price target
$EW
Industrial Specialties
Health Care
Wolfe Research downgraded Edwards Lifesciences from Peer Perform to Underperform and set a new price target of $60.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/24/2025 | $80.00 | Neutral → Overweight | Piper Sandler |
| 1/30/2025 | $75.00 → $90.00 | Hold → Buy | Stifel |
| 1/16/2025 | $60.00 | Peer Perform → Underperform | Wolfe Research |
| 12/16/2024 | Neutral → Buy | BofA Securities | |
| 10/11/2024 | $70.00 | Equal-Weight | Morgan Stanley |
| 9/18/2024 | $85.00 → $70.00 | Buy → Hold | Jefferies |
| 7/31/2024 | Neutral → Outperform | Daiwa Securities | |
| 7/29/2024 | Underperform → Peer Perform | Wolfe Research |
Piper Sandler upgraded Edwards Lifesciences from Neutral to Overweight and set a new price target of $80.00
Stifel upgraded Edwards Lifesciences from Hold to Buy and set a new price target of $90.00 from $75.00 previously
Wolfe Research downgraded Edwards Lifesciences from Peer Perform to Underperform and set a new price target of $60.00